CN203953886U - The unidirectional support of drain in a kind of ascites - Google Patents
The unidirectional support of drain in a kind of ascites Download PDFInfo
- Publication number
- CN203953886U CN203953886U CN201420382351.9U CN201420382351U CN203953886U CN 203953886 U CN203953886 U CN 203953886U CN 201420382351 U CN201420382351 U CN 201420382351U CN 203953886 U CN203953886 U CN 203953886U
- Authority
- CN
- China
- Prior art keywords
- rack body
- ascites
- unidirectional
- drain
- support
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010003445 Ascites Diseases 0.000 title claims abstract description 51
- 230000000151 anti-reflux effect Effects 0.000 claims abstract description 25
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 6
- 229910002027 silica gel Inorganic materials 0.000 claims description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052737 gold Inorganic materials 0.000 claims description 4
- 239000010931 gold Substances 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 229910052715 tantalum Inorganic materials 0.000 claims description 3
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 3
- 210000002989 hepatic vein Anatomy 0.000 abstract description 18
- 210000004185 liver Anatomy 0.000 abstract description 8
- 210000003240 portal vein Anatomy 0.000 abstract description 5
- 210000003445 biliary tract Anatomy 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 210000002767 hepatic artery Anatomy 0.000 abstract description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 230000003187 abdominal effect Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 206010037423 Pulmonary oedema Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000006193 Pulmonary infarction Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 206010065441 Venous haemorrhage Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001194 anti-hemostatic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 208000007232 portal hypertension Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000007575 pulmonary infarction Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Abstract
The utility model discloses the unidirectional support of drain in a kind of ascites, comprise rack body, rack body one end is provided with location structure, and the external diameter of this location structure is greater than the external diameter of rack body; The inwall of rack body is covered with the inwall film that can not see through liquid, is provided with and only allows liquid from being provided with one end of location structure, to flow to the unidirectional antireflux valve of the other end in described rack body.When this utility model is used, puncture is outside liver, as long as blood vessel diameter is greater than 4mm, point of puncture, at hepatic vein far-end, both can avoid damaging large portal vein, Hepatic artery and biliary tract, avoids again support to stop that large hepatic vein backflow causes congestion.With respect to the importance of TIPS puncture needle angle adjustment, after this product introduction hepatic vein, can not use orientation lever, directly outside liver, puncture.
Description
Technical field
This utility model relates to a kind of for ascites is back to hepatic vein, to reduce the unidirectional support of drain in the ascites of patient's ascites
Background technology
In the patients with ascites that the portal hypertension causing at liver cirrhosis causes, after ascites reduces by treatment, Portal Vein Flow can increase.Conventional method is diuretic treatment, discharge ascites, ascites recovery/bypass, treatment by Chinese herbs at present.It is suitable that diuretic is used, in order to avoid cause that internal metabolism is disorderly.Discharge ascites is a kind ofly can receive very soon the method that is satisfied with therapeutic effect, but easily causes the infection that albumin lacks and abdominal paracentesis causes.Ascites reclaims and comprises ascites direct feedback vein, concentrated ascites reinfusion vein and concentrated ascites reinfusion abdominal cavity.Being about to ascites and extracting in patient body, without or pass through ultrafiltration dialysis, the more all or part of arteriovenous loop that is fed back to patient.The method can effectively increase circulation volume, makes urine amount, urine sodium discharge and increase, and ascites reduces, and can avoid discharging protein and the electrolyte loss that ascites causes.But because the method generally need be through extra-corporeal ultrafiltration, concentrated, the subcutaneous pipe of putting, fistula mouth place is subject to germ contamination; Pipeline stroke is longer, easily stops up and is difficult to and process; Due to gravity and patient body position, cause feedback effect not good enough; Hemodialysis and ascites back transfusion separately carry out, more time-consuming; And the concentrated ascites of too fast too much input can cause acute lung edema and Esophagus venous bleeding, the complication such as disseminated inravascular coagulation tend to jeopardize patient's life.Bypass comprises peritoneovenous shunt (PVS), porto-caval shunt (TIPS), surgery door-vena systemica bypass in jugular vein liver.Principle is the body circulation to patient by ascites drainage, reduces portal vein pressure, thereby reduces ascites, relief of symptoms, avoid repeatedly abdomen to wear the method for discharge opeing.Shortcoming is that complication is many, as narrow in isocon or inaccessible, heart failure, DIC, pulmonary edema, pulmonary infarction, upper gastrointestinal hemorrhage, arrhythmia, infection etc.; Surgery door-vena systemica bypass operation is complicated, wound is large, may cause that sb.'s illness took a turn for the worse.
Utility model content
Utility model object: technical problem to be solved in the utility model is for the deficiencies in the prior art, provides the unidirectional support of drain in a kind of ascites.
In order to solve the problems of the technologies described above, the utility model discloses the unidirectional support of drain in a kind of ascites, comprise rack body, rack body one end is provided with location structure, and the external diameter of this location structure is greater than the external diameter of rack body; The inwall of rack body is covered with the inwall film that can not see through liquid, is provided with and only allows liquid from being provided with one end of location structure, to flow to the unidirectional antireflux valve of the other end in described rack body.
In this utility model, described rack body and the location structure network structure for being made by Ultimum Ti.
In this utility model, described inwall membrane material is silica gel, acetone or silicone.In support, cover after inwall film can make it be placed in body and be difficult for displacement.
In this utility model, described location structure is umbrella projection or mushroom head projection.
In this utility model, the film lobe number of the end of described unidirectional antireflux valve is 2～4.Antireflux valve material is silica gel, acetone or silicone
In this utility model, on rack body or location structure, be provided with mark structure, the material of mark structure is gold, platinum or tantalum.1～20 of mark structure is not etc.
In this utility model, the surface cancellated wiry of Ultimum Ti is provided with concaveconvex structure or bulge-structure.1～10 of bulge-structure quantity is not etc.Concaveconvex structure or bulge-structure adopt as method processing such as laser ablation, plasma treatment, sandblasts.Or adopt tiny silk material to increase little projection at rack surface.
In this utility model, the film lobe number of the end of described unidirectional antireflux valve is 2～4.
The applicant has found problems of the prior art, thinks and is necessary to set up the direct return flow line between abdominal cavity and the specific vein of liver, relies on special support to be directly connected, thereby reach, reduces portal vein pressure, reduces ascites, the therapeutic purposes of relief of symptoms; And greatly reduce and infect and all kinds of complication, avoided as far as possible the defect of prior art.
This utility model support, is monitored and is placed in hepatic vein by X-ray, is communicated with ascites extreme lower position and hepatic vein, under the effect of autologous negative pressure, allows ascites be back to hepatic vein by support, reduces ascites.Mount proximal end is designed with unidirectional antireflux valve, can allow ascites pass through, but can stop the blood in hepatic vein to flow into abdominal cavity by support.After operation, support is inserted in patient body, does not affect daily life, and can, because of the discharge ascites of pure, not cause albuminous shortage.The method is equally applicable to the ascites that abdominal cavity/tumor of pelvic cavity causes.
Beneficial effect: compare with existing TIPS operation, when this utility model is used, puncture is outside liver, as long as blood vessel diameter is greater than 4mm, point of puncture, at hepatic vein far-end, both can avoid damaging large portal vein, Hepatic artery and biliary tract, avoided again support to stop that large hepatic vein backflow causes congestion.With respect to the importance of TIPS puncture needle angle adjustment, after this product introduction hepatic vein, can not use orientation lever, directly outside liver, puncture.
This utility model is simple in structure, is easy to processing, can realize autologous ascites and reflux, and can not cause albuminous shortage because of the discharge ascites of pure, and do not affect routine work and life.
Accompanying drawing explanation
Below in conjunction with the drawings and specific embodiments, this utility model is done further and illustrated, above-mentioned and/or otherwise advantage of the present utility model will become apparent.
Fig. 1 is support overall structure schematic diagram.
Fig. 2 a～Fig. 2 c is that antireflux film lobe is counted schematic diagram.
Fig. 3 is the local enlarged diagram of labelling and bossing.
Fig. 4 is unidirectional antireflux valve placing rack medium position schematic diagram.
Fig. 5 is for inserting human body schematic diagram.
Fig. 6 is the partial enlarged drawing of Fig. 5.
The specific embodiment
The utility model discloses the unidirectional support of drain in a kind of ascites, comprise rack body, rack body one end is provided with location structure, and the external diameter of this location structure is greater than the external diameter of rack body; The inwall of rack body is covered with the inwall film that can not see through liquid, is provided with and only allows liquid from being provided with one end of location structure, to flow to the unidirectional antireflux valve of the other end in described rack body.Described rack body and the location structure network structure for being made by Ultimum Ti.Described inwall membrane material is silica gel, acetone or silicone.Described location structure is umbrella projection or mushroom head projection.The film lobe number of the end of described unidirectional antireflux valve is 2～4.On rack body or location structure, be provided with mark structure, the material of mark structure is gold, platinum or tantalum.The surface cancellated wiry of Ultimum Ti is provided with concaveconvex structure or bulge-structure.The film lobe number of described unidirectional antireflux valve is 2～4.
Antireflux valve is arranged on mount proximal end, can only to near-end, be opened by far-end, and its principle is: when ascites is passed through support, abdominal pressure is opened film lobe, and ascites is by after support, and the absorption of antireflux film lobe is drawn close, prevention caval vein blood reflux stream bonded to each other.Antireflux valve can adopt the product of prior art, and antireflux valve is a valve, and is provided with opening, and valve can only be by being opened to near-end by far-end, and its rigging position can be on support straight section, and position is not limit.
The network structure that Ultimum Ti is made, diameter d is 2～10mm, length 5～80mm.
The width on far-end umbrella limit (umbrella limit external diameter-straight section external diameter) is 1～6mm.
Included angle A between umbrella limit and support straight section is 45 °～135 °.
Embodiment
As shown in Figure 1, rack body 1 is made by Ultimum Ti silk, and far-end 1a is umbrella location structure 2, and near-end 1b is cylindrical straight section.During use, far-end is fixed on outside Glisson's capsule, be communicated with hepatic vein and abdominal cavity, near-end is with unidirectional antireflux valve 3, as shown in Fig. 2 a～Fig. 2 c, it is 2～4 that the antireflux film lobe of the end of unidirectional antireflux valve 3 is counted 3a, and as shown in Figure 3, unidirectional antireflux valve is assemblied in the position of close near-end 1b in support straight section, in support integral body, cover inwall film (not shown), covering material is silica gel.Far-end beveled structure can well be fixed on outside Glisson's capsule.By autologous negative pressure, realize ascites from abdominal cavity to hepatic venous unidirectional passing through, anti-Hemostatic Oral Liquid flows into abdominal cavity by support simultaneously, realizes autologous ascites and reclaims.Antireflux valve material is silica gel.
As shown in Figure 3, for easy to use in operation process, be provided with the labelling 4 of some on support, marker material is gold.Quantity is determined according to stent size, and from 10, support Ji San limit, two ends and straight section transition position must have labelling, and determine according to supporting structure other position.Ultrasonic lower easy to use for making, adopt tiny silk material to increase by 5 little projections 5 at rack surface.
As shown in Figure 5 and Figure 6, during operation, through jugular puncture, the lower introducing of seal wire guiding 10F sheath, is introduced the capable hepatic phlebography of conduit and is determined point of puncture to postcava hepatic vein opening level through superior vena cava, right room, sends into puncture needle, to abdominal paracentesis, keep somewhere seal wire, dilated penetration road, implants the unidirectional support of this utility model.The near-end 1b of unidirectional support is positioned at liver vessel 6, far-end 1a is positioned at outside liver peplos 7, effect due to abdominal cavity and hepatic vein pressure differential and unidirectional antireflux film lobe, make ascites 8 directly enter hepatic vein from abdominal cavity by this device, the circulation of participation body, and hepatic venous blood can instead not flow to abdominal cavity.
Embodiment 2
As shown in Figure 4, in the present embodiment, the middle part of unidirectional antireflux valve 3 between far-end 1a and near-end 1b.All the other are identical with embodiment 1.
Embodiment 3
Adopt the unidirectional support of drain in the ascites of this utility model structure, through 32 routine secret clinical datas, use, 3 days mean treatment time, compare with conventional art, conventional art matched group, target hepatic vein RBC number is average 4.452, hemoglobin average 75.2; Within 24 hours, abdominal circumference reduces average 1.7cm.Adopt the experimental group of the present embodiment, target hepatic vein RBC number is average 6.752, and average 114.6,24 hours abdominal circumferences of hemoglobin reduce average 3cm.The first two is scolded in bright the present embodiment target hepatic vein ascites drainage, and blood is diluted better effects if, and abdominal circumference reduces explanation the present embodiment ascites and disappears faster.The present embodiment has been avoided the side effect of Drug therapy, reduces above-mentioned all hidden danger of external drainage simultaneously.
This utility model provides the unidirectional support of drain in a kind of ascites; method and the approach of this technical scheme of specific implementation are a lot; the above is only preferred implementation of the present utility model; should be understood that; for those skilled in the art; not departing under the prerequisite of this utility model principle, can also make some improvements and modifications, these improvements and modifications also should be considered as protection domain of the present utility model.In the present embodiment not clear and definite each ingredient all available prior art realized.
Claims (8)
1. the unidirectional support of drain in ascites, is characterized in that, comprise rack body, rack body one end is provided with location structure, and the external diameter of this location structure is greater than the external diameter of rack body; The inwall of rack body is covered with the inwall film that can not see through liquid, is provided with and only allows liquid from being provided with one end of location structure, to flow to the unidirectional antireflux valve of the other end in described rack body.
2. the unidirectional support of drain in a kind of ascites according to claim 1, is characterized in that, described rack body and the location structure network structure for being made by Ultimum Ti.
3. the unidirectional support of drain in a kind of ascites according to claim 1, is characterized in that, described inwall membrane material is silica gel, acetone or silicone.
4. the unidirectional support of drain in a kind of ascites according to claim 1, is characterized in that, described location structure is umbrella projection or mushroom head projection.
5. the unidirectional support of drain in a kind of ascites according to claim 2, is characterized in that, the film lobe number of the end of described unidirectional antireflux valve is 2～4.
6. the unidirectional support of drain in a kind of ascites according to claim 1, is characterized in that, on rack body or location structure, be provided with mark structure, the material of mark structure is gold, platinum or tantalum.
7. the unidirectional support of drain in a kind of ascites according to claim 1, is characterized in that, the surface cancellated wiry of Ultimum Ti is provided with concaveconvex structure or bulge-structure.
8. the unidirectional support of drain in a kind of ascites according to claim 1, is characterized in that, the film lobe number of the end of described unidirectional antireflux valve is 2～4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420382351.9U CN203953886U (en) | 2014-07-10 | 2014-07-10 | The unidirectional support of drain in a kind of ascites |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420382351.9U CN203953886U (en) | 2014-07-10 | 2014-07-10 | The unidirectional support of drain in a kind of ascites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203953886U true CN203953886U (en) | 2014-11-26 |
Family
ID=51914530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420382351.9U Expired - Lifetime CN203953886U (en) | 2014-07-10 | 2014-07-10 | The unidirectional support of drain in a kind of ascites |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203953886U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104042374A (en) * | 2014-07-10 | 2014-09-17 | 李麟荪 | Abdominal dropsy internal-drainage one-way support |
-
2014
- 2014-07-10 CN CN201420382351.9U patent/CN203953886U/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104042374A (en) * | 2014-07-10 | 2014-09-17 | 李麟荪 | Abdominal dropsy internal-drainage one-way support |
| CN104042374B (en) * | 2014-07-10 | 2017-02-08 | 李麟荪 | Abdominal dropsy internal-drainage one-way support |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2016086832A1 (en) | Indwelling needle having sustained release positive pressure | |
| CN104436417B (en) | One kind is used for perfusion thrombolysis catheter in human vas | |
| US6113568A (en) | Vein catheter for coaxial blood stream and use of a split needle for its introduction in a vein | |
| CN103007396B (en) | Injection device used under medical endoscope | |
| CN203953886U (en) | The unidirectional support of drain in a kind of ascites | |
| US20070051681A1 (en) | Device and machine for regenerating a human liver | |
| CN203315053U (en) | Pre-made water bag for maxillary sinus fracture | |
| CN210812904U (en) | A change and flow device for intestinal juice drainage | |
| CN104042374A (en) | Abdominal dropsy internal-drainage one-way support | |
| US11452802B2 (en) | Perfusion device and method for operating same | |
| CN101284153B (en) | Disposable coloclysis administer drug dialyser | |
| CN206325055U (en) | Integral type bladder irrigator | |
| CN204147336U (en) | The disposable colon clysis drug-supplying system improved | |
| CN209059558U (en) | A kind of novel ascitic vena hepatica turn of tidal stream controllable check valve preventing thrombosis holder device | |
| CN208852115U (en) | A kind of portable three-cavity catheter | |
| CN207640722U (en) | A kind of haemodialysis equipment | |
| CN208492929U (en) | Women DJ pipe takes out Simple assisting device | |
| CN206492052U (en) | A kind of artery lateral line | |
| CN105879138B (en) | The plasmapheresis device extracorporeal circulation pipeline of changeable blood separator | |
| CN208160791U (en) | A kind of neurosurgery washing conversion device | |
| CN209679125U (en) | A kind of diacan | |
| CN209347712U (en) | Flushing drainage tube for neck anastomosis fistula after esophageal cancer operation | |
| CN211357029U (en) | Timely bile back transfusion device | |
| CN103977465B (en) | A kind of implantating biological artificial kidney device | |
| CN212914051U (en) | Peritoneal dialysis catheter suitable for patient with thin and small peritoneal dialysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 210000 No. 3, No. 1, Shimao new town, 89 Nantong Road, Jiangsu, Nanjing, Binjiang, 1905 Patentee after: Li Linsun Patentee after: Fan Yong Patentee after: Micro-Tech (Nanjing) Co.,Ltd. Address before: 210000 No. 3, No. 1, Shimao new town, 89 Nantong Road, Jiangsu, Nanjing, Binjiang, 1905 Patentee before: Li Linsun Patentee before: Fan Yong Patentee before: MICRO-TECH (NANJING) Co.,Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20180417 Address after: 210061 hi tech Industrial Development Zone, Pukou District, Jiangsu, hi tech Road, No. three, No. 10, No. Patentee after: Micro-Tech (Nanjing) Co.,Ltd. Address before: 210000 No. 3, No. 1, Shimao new town, 89 Nantong Road, Jiangsu, Nanjing, Binjiang, 1905 Co-patentee before: Fan Yong Patentee before: Li Linsun Co-patentee before: Micro-Tech (Nanjing) Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 210061, No. 10, hi tech three road, Pukou hi tech Industrial Development Zone, Nanjing, Jiangsu Patentee after: Nanwei Medical Technology Co.,Ltd. Address before: 210061, No. 10, hi tech three road, Pukou hi tech Industrial Development Zone, Nanjing, Jiangsu Patentee before: Micro-Tech (Nanjing) Co.,Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CX01 | Expiry of patent term |
Granted publication date: 20141126 |
|
| CX01 | Expiry of patent term |